European clinical guidelines for hyperkinetic disorder - First upgrade

European Child and Adolescent Psychiatry, Supplement

Volumn 13, Issue 1, 2004, Pages

  Taylor, Eric ^a   Döpfner, Manfred ^b   Sergeant, Joseph ^c   Asherson, Philip ^a   Banaschewski, Tobias ^d   Buitelaar, Jan ^e   Coghill, David ^f   Danckaerts, Marina ^g   Rothenberger, Aribert ^d   Sonuga Barke, Edmund ^h   Steinhausen, Hans Christoph ⁱ   Zuddas, Alessandro ^j  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF COLOGNE   (Germany)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF DUNDEE   (United Kingdom)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

ⁱ UNIVERSITY OF ZURICH   (Switzerland)

^j UNIVERSITY OF CAGLIARI   (Italy)

more..

Author keywords

ADHD; Children; European; Guidelines; HKS

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ATOMOXETINE; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; FISH OIL; FLUOXETINE; GUANFACINE; HALOPERIDOL; IMIPRAMINE; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PEMOLINE; PHENOBARBITAL; PHENYTOIN; PIMOZIDE; PLACEBO; PRIMIDONE; PRIMROSE OIL; PSYCHOSTIMULANT AGENT; RISPERIDONE; STEROID; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ALGORITHM; ANOREXIA; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BIPOLAR DISORDER; CHILD BEHAVIOR; CHILD PARENT RELATION; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONDUCT DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DEVELOPMENTAL COORDINATION DISORDER; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG OVERDOSE; DYSPHORIA; EMOTIONAL DISORDER; EUROPE; FAMILY; FEMALE; HEADACHE; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERACTIVITY; HYPOTENSION; INTERVIEW; LEARNING DISORDER; LIVER FAILURE; MALE; MANIA; META ANALYSIS; NAUSEA; PARENT; PATHOGENESIS; PRACTICE GUIDELINE; PRESCHOOL CHILD; PREVALENCE; PSYCHIATRIC DIAGNOSIS; PSYCHOMETRY; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RASH; RATING SCALE; REVIEW; SCHOOL; SCHOOL CHILD; SIDE EFFECT; SLEEP DISORDER; SOCIAL SUPPORT; TIC; VISUAL IMPAIRMENT; XEROSTOMIA;

ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; CONDUCT DISORDER; DIAGNOSIS, DIFFERENTIAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EUROPE; GENE FREQUENCY; GUIDELINES; HUMANS; HYPERKINESIS; INTERNATIONAL CLASSIFICATION OF DISEASES; LEARNING DISORDERS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHYLPHENIDATE; NERVE TISSUE PROTEINS; PREVALENCE; PSYCHOMETRICS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; TIC DISORDERS;

EID: 4444352968     PISSN: 14335719     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00787-004-1002-x     Document Type: Review

References (190)

1. Abikoff H (1991) Cognitive training in ADHD children: less to it than meets the eye. J Learning Disabil 24:205-209
2. Aman MG, Turbott SH (1991) Prediction of clinical response in children taking methylphenidate. J Autism Devel Disord 21:211-228
3. Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL; Risperidone Disruptive Behavior Study Group (2002) Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 159:1337-1346
4. Arnsten AFT (2001) Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex. In: Solanto MV, Arnsten AFT, Castellanos FX (eds) Stimulant Drugs and ADHD. Basic and Clinical Neuroscience. New York, NY, Oxford University Press, pp 185-208
5. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH (1995) Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochemistry 65:1157-1165
6. Bakker SC, van der Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL, Monsuur AJ, van 't Slot R, Minderaa RB, Gunning WB, Pearson PL, Sinke RJ (2003) A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Human Gen 72:1251-1260
7. Banaschewski T, Brandeis D, Heinrich H, Albrecht B, Brunner E, Rothenberger A (2003) Questioning inhibitory control as the specific deficit of ADHD - evidence from brain electrical activity. J Neural Transm (2004) 111(7):841-864 Epub 2003 Oct 24
8. Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A (2004) Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry 13(Suppl 1):I102-I116
9. Barkley RA (1997) Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121:65-94
10. Barkley RA (1988) The effects of methylphenidate on the interactions of preschool ADHD children with their mothers. J Am Acad Child Adolesc Psychiatry 27:336-341
11. nd edn. New York, Guilford Press
12. Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M, Schachar R, Tannock R, Kennedy JL (2000) Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Molecular Psychiatry 54:405-409
13. Barry RJ, Johnstone SJ, Clarke AR (2003) A review of electrophysiology in attention-deficit/hyperactivity disorder: II. Event-related potentials. Clin Neurophysiol 114:184-198
14. Berger A, Posner MI (2000) Pathologies of brain attentional networks. Neurosci Biobehav Rev 24:3-5
15. Berkovitch M, Pope E, Phillips J, Koren G (1995) Pemoline-associated fulminant liver failure: testing the evidence for causation. Clin Pharmacol Therapy 57:696-698
16. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek MS, Steingard R, et al. (1992) Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 49:728-738
17. Biederman J, Milberger S, Faraone SV, Kiely K, Guite J, Mick E, Ablon S, Warburton R, Reed E (1995) Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity. Arch Gen Psychiatry 52:464-470
18. Blanz B, Lehmkuhl G, Poustka F, Remschmidt H, Schmidt M, Warnke A (1999) Guidelines for diagnosis and therapy. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 27:91-92
19. Bor W, Sanders MS, Markie-Dadds C (2002) The effects of the tripe P-Positve Parenting Program on preschool children with co-occurring disruptive behavior and attentional/hyperactive difficulties. J Abnorm Child Psychol 30:571-589
20. Borcherding BG, Keysor CS, Rapoport JL, Elia J, Amass (1990) Motor/vocaltics and compulsive behaviors on stimulant drugs: is there a common vulnerability? Psychiatry Res 33:83-94
21. Boyle MH, Offord DR, Hoffmann HG, Catlin GP, Byles JA, Cadman DT, Crawford JW, Links PS, Rae-Grant NI Szatmari P (1987) Ontario Child Health Study: I Methodology; II. Six-month prevalence of disorder and rates of service utilisation. Arch Gen Psychiatry 44:826-836
22. Bramble D (2003) Annotation: The use of psychotropic medications in children: a British view. J Child Psychol Psychiatry 44:169-179
23. Brandeis D, Banaschewski T, Baving L, Georgiewa P, Blanz B, Warnke A, Steinhausen HC, Rothenberger A, Scheuerpflug P (2002) Multicenter P300 brain mapping of impaired attention to cues in hyperkinetic children. J Am Acad Child Adolesc Psychiatry 41:990-998
24. Breslau N, Brown GG, DelDotto JE, Kumar S, Ezhuthachan S, Andreski P, Hufnagle KG (1996) Psychiatric sequelae of low birth weight at 6 years of age. J Abnorm Child Psychol 24:385-400
25. Buitelaar JK, Kooij JJS (2000) Aandachtstekort/hyperactiviteitsstoornis - ADHD. Achtergronden, diagnostiek en behandeling. Nederlands Tijdschrift voor Geneeskunde 144:1716-1723
26. Buitelaar JK (2002) Epidemiology of Attention-deficit/Hyperactivity Disorder: what have we learned over the last decade? In: Sandberg S (ed) Hyperactivity Disorders. Cambridge, Cambridge University Press, pp 30-63
27. Carter CM, Urbanowicz M, Hemsley R, Mantilla L, Strobel S, Graham PJ, Taylor E (1993) Effects of a few food diet in attention deficit disorder. Arch Dis Childhood 69:564-568
28. Castellanos FX (2001) Neuroimaging studies of ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX (eds) Stimulant Drugs and ADHD. Basic and Clinical Neuroscience. New York, NY, Oxford University Press, pp 243-258
29. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, Blumenthal JD, James RS, Ebens CL, Walter JM, Zijdenbos A, Evans AC, Giedd JN, Rapoport JL (2002) Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. J Am Med Assoc 288:1740-1748
30. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A, Huckett L, Sharp J, Batten C, Fernando S, Ozbay F, Yazgan Y, Simonoff E, Thompson M, Taylor E, Asherson P (2001) Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Molecular Psychiatry 6:425-428
31. Daly G, Hawi Z, Fitzgerald M, Gill M (1999) Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Molecular Psychiatry 4:192-196
32. nd edn. Goettingen, Hogrefe
33. nd edn. Köln, Deutscher Ärzte Verlag, pp 237-249
34. Döpfher M, Schmeck K, Poustka F, Berner W, Lehmkuhl G, Verhulst F (1996) Verhaltensauffaelligkeiten von Kindern und Jugendlichen in Deutschland, den Niederlanden und den U.S.A., Eine kulturvergleichende Studie mit der Child Behavior Checklist. Nervenarzt 67:960-967
35. Döpfner M, Frölich J, Lehmkuhl G (2000) Hyperkinetische Störungen. Leitfaden Kinder- und Jugendpsychotherapie Vol 1. Göttingen, Hogrefe
36. Döpfner M, Breuer D, Schürmann S, Wolff Metternich T, Rademacher C, Lehmkuhl G (2004) Effectiveness of an individually tailored multimodal treatment in children with Attention Deficit Hyperactivity Disorder - global outcome. Eur Child Adolesc Psychiatry 13(Suppl 1):I117-I129
37. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ (1999) Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354:2132-2133
38. DuPaul GJ, Eckert TL (1997) The effects of school-based interventions for Attention Deficit Hyperactivity Disorder: A meta-analysis. School Psychol Rev 23:5-27
39. DuPaul G, McGoey K, EcKert T, Van-Brackle J (2001) Preschool children with attention-deficit/hyperactivity disorder: Impairments in behavioral, social, and school functioning. J Am AcadChild Adolesc Psychiatry 40:508-515
40. DuPaul GJ, Stoner G (1994) ADHD in the Schools. Assessment and Intervention Strategies. New York, Guilford
41. Egger J, Carter CM, Graham PJ, Gumley D, Soothill JF (1985) Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet i:540-545
42. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM (1998) DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci 18:5901-5907
43. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen RM (1999) High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry 156:I209-I215
44. Ernst M, Liebenauer LL, Tebeka D, Jons PH, Eisenhofer G, Murphy DL, Zametkin AJ (1997) Selegiline in ADHD adults: plasma monoamines and monoamine metabolites. Neuropsychopharmacology 16:276-284
45. Faraone SV, Biederman J (1994) Is attention deficit hyperactivity disorder familial? Harvard Rev Psychiatry I:271-287
46. Faraone SV, Doyle AE, Mick E, Biederman J (2001) Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 158:1052-1057
47. Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN, Biederman J (1997) Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 48:589-601
48. Feingold BF (1975) Hyperkinesis and learning disabilities linked to artificial food flavors and colors. Am J Nursing 75:797-803
49. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S (2001) The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics 1:152-156
50. Gadow K, Nolan E (2002) Differences between preschool children with ODD, ADHD, and ODD & ADHD symptoms. J Child Psychol Psychiatry 43:191-201
51. Gillberg C, Carlstrom G, Rasmussen P (1983) Hyperkinetic disorders in children with perceptual, motor and attentional deficits. J Child Psychol Psychiatry 24:233-246
52. Gillberg C, Melander H, von Knorring A.-L, Janols L-O, Thernlund G, Haeggloef B, Eideval-Wallin L, Gustaffson P, Kopp S (1997) Long-term stimulant treatment of children with Attention-Deficit Hyperactivity Disorder symptoms: A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 54:857-864
53. Gillberg C (2003) Deficits in attention, motor control, and perception: a brief review. Arch Dis Childhood 88:904-910
54. Gillberg C, Gillberg IC, Rasmussen P, Kadesjö B, Söderström H, Råstam M, Johnson M, Rothenberger A, Niklasson L (2004) Co-existing disorders in ADHD - implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 13(Suppl 1):I80-I92
55. Gjone H, Stevenson J, Sundet JM (1996) Genetic influence on parent-reported attention-related problems in a Norwegian general population twin sample. J Am Acad Child Adolesc Psychiatry 35:588-598
56. Glow RA (1981) Cross-validity and normative data on the Conners' Parent and Teacher Rating Scales. In: Gadow KD, Loney J (eds) The Psychosocial Aspects of Drug Treatment for Hyperactivity. Boulder, CO, Westview Press, pp 107-150
57. Goodman R, Stevenson J (1989) A twin study of hyperactivity: I An examination of hyperactivity scores and categories derived from Rutter Teacher and Parent Questionnaires. II. The aetiological role of genes, family relationships, and perinatal adversity. J Child Psychol Psychiatry 30:671-710
58. Green WH (1991) Child and Adolescent Clinical Psychopharmacology. Baltimore, Williams & Wilkins
59. Greenhill LL, Setterberg S (1993) Pharmacotherapy of disorders of adolescents. Psychiatry Clinics of North America 16:793-814
60. Gross MD (1995) Buspirone in ADHD with ODD. J Am Acad Child Adolesc Psychiatry 34:1260
61. Gross-Tsur V, Manor O, v.d. Meere J, Josphe A, Shalev RS (1997) Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective? J Pediatr 130:670-674
62. Gualtieri CT, Ondrusek MG, Finley C (1985) Attention deficit disorder in adults. Clin Neuropharmacol 8:343-356
63. Halperin JM, Newcorn JH, Schwartz ST, Sharma V, Siever LJ, Koda VH, Gabriel S (1997) Age-related changes in the association between serotonergic function and aggression in boys with ADHD. Biol Psychiatry 41:682-689
64. Handen BL, Feldman HM, Lurier A, Murray PJH (2000) Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. J Am Acad Child Adolesc Psychiatry 38:805-812
65. Harrington R, Myatt T (2003) Is preadolescent mania the same condition as adult mania? A British perspective. Biol Psychiatry 53:961-969
66. Hawi Z, Dring M, Kirley A, Foley D, Kent L, Craddock N, Asherson P, Curran S, Gould A, Richards S, Lawson D, Pay H, Turic D, Langley K, Owen M, O'Donovan M, Thapar A, Fitzgerald M, Gill M (2002) Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Molecular Psychiatry 7:718-725
67. Hazell PL, Carr V, Lewin TJ, Sly K (2003) Manic symptoms in young males with ADHD predict functioning but not diagnosis after 6 years. J Am Acad Child Adolesc Psychiatry 42:552-560
68. Hemmer SA, Pasternak JF, Zecker SG, Trommer BL (2001) Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 24:99-102
69. rd edn. Oxford, Blackwell Scientific Publications, pp 858-879
70. Hill P, Taylor E (2001) An auditable protocol for the medical management of ADHD or hyperkinetic disorder. Arch Dis Childhood 84:404-409
71. Huss M, Lehmkuhl U (2002) Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies. J Attention Disord 6 (Suppl 1):S65-S71
72. Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R (1998) The treatment of attention-deficit/hyperactivity disorder: an evidence report. Agency for Healthcare Research and Quality, US Department of Health and Human Services, Rockville, MD
73. Jadad AR, Booker L, Gauld M, Kakuma R, Boyle M, Cunningham CE, Kim M, Schachar R (1999) The treatment of attention-deficit hyperactivity disorder: an annotated bibliography and critical appraisal of published systematic reviews and meta-analysis. Can J Psychiatry 44:1025-1035
74. James A, Taylor EA (1990) Sex differences in the hyperkinetic syndrome of childhood. J Child Psychol Psychiatry 31:437-446
75. Johnston C, Fine S (1993) Methods of evaluating methylphenidate in children with attention deficit hyperactivity disorder: acceptability, satisfaction, and compliance. J Pediatr Psychol 18:717-730
76. Kadesjö B, Gillberg C (2001) The comorbidity of ADHD in the general population of Swedish school-age children. J Child Psychol Psychiatry 42:487-492
77. Kahn RS, Khoury J, Nichols WC, Lanphear BP (2003) Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. J Pediatr 143:104-110
78. Kaplan BJ, McNicol J, Conte RA, Moghadam HK (1989) Dietary replacement in preschool-aged hyperactive boys. Pediatrics 83:7-17
79. Kent L, Craddock N (2003) Is there a relationship between attention deficit hyperactivity disorder and bipolar disorder? J Affective Disord 73:211-221
80. Klein RG, Wender P (1995) The role of methylphenidate in psychiatry. Arch Gen Psychiatry 52:429-433
81. Köster I, Schubert I, Doepfner M, Adam C, Ihle P, Lehmkuhl G (2004) Hyperkinetische Störungen bei Kindern und Jugendlichen: Zur Häufigkeit des Behandlungsanlasses in der ambulanten Versorgung nach den Daten der Versichertenstichprobe AOK Hessen/KV Hessen (1998-2001). Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie (in press)
82. Krause KH, Krause J (2000) Ist Methylphenidat bei Komorbidität von Epilepsie und Aufmerksamkeitsdefizit, - hyperaktivitätsstörungen kontraindiziert oder nicht? Aktuelle Neurologie 27:72-76
83. Kuntsi J, Oosterlaan J, Stevenson J (2001) Psychological mechanisms in hyperactivity: I Response inhibition deficit, working memory impairment, delay aversion, or something else? J Child Psychol Psychiatry 42:199-210
84. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K (2000) Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neuroscience Letters 285:107-110
85. Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW, Barkley RA, Newcorn J, Jensen P, Richters J et al. (1994) DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 151:1673-1685
86. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL (1996) Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiatry 1:121-124
87. Levin FR, Evans SM, McDowell DM, Brooks DJ, Nunes E (2002) Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addictive Dis 21:1-16
88. Leung PWL, Luk SL, Ho TP, Taylor E, Mak FL, Bacon-Shone J (1996) The diagnosis and prevalence of hyperactivity in Chinese schoolboys. Br J Psychiatry 168:486-496
89. Lord J, Paisley S (2000) The Clinical Effectiveness and Cost-Effectiveness of Methylphenidate for Hyperactivity in Childhood. Version 2.London: National Institute for Clinical Excellence
90. Lynskey MT, Hall W (2001) Attention deficit hyperactivity disorder and substance use disorders: Is there a causal link? Addiction 96:815-822
91. McGee R, Share DL (1988) Attention deficit disorder-hyperactivity and academic failure: which comes first and what should be treated? J Am Acad Child Adolesc Psychiatry 27:318-325
92. McGee R, Williams S, Silva PA (1987) A comparison of girls and boys with teacher-identified problems of attention. J Am Acad Child Adolesc Psychiatry 26:711-717
93. Mariani MA, Barkley RA (1997) Neuropsychological and academic functioning in preschool boys with attention deficit/hyperactivity disorder. Devel Neuropsychol 13:111-129
94. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM (2002) Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Gen 12:207-215
95. Mattes JA, Gittelman R (1981) Effects of artificial food colorings in children with hyperactive symptoms. Arch Gen Psychiatry 38:714-718
96. Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer (2001) Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 108:E83
97. Mick E, Biederman J, Faraone SV (1996) Is season of birth a risk factor for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 35:1470-1476
98. Milberger S, Biederman J, Faraone SV, Guite J, Tsuang MT (1997) Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: issues of gene-environment interaction. Biol Psychiatry 41:65-75
99. Mill J, Asherson P, Browes C, D'Souza U, Craig I (2002a) Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Gen 114:975-979
100. Mill J, Curran S, Kent L, Gould A, Huckett L, Richards S, Taylor E, Asherson P (2002b) Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder. Am J Med Gen 114:269-271
101. Misener VL, Luca P, Azeke O, Crosbie J, Waldman I, Tannock R, Roberts W, Malone M, Schachar R, Ickowicz A, Kennedy JL, Barr CL (2004) Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder. Molecular Psychiatry 9:500-509
102. Moll GH, Heinrich H, Trott G, Wirth S, Rothenberger A (2000) Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neuroscience Letters 284:121-125
103. Moll GH, Rothenberger A, Ruether E, Huether G (2002) Developmental psychopharmacology in child and adolescent psychiatry: results of experimental animal studies with fluoextine and methylphenidate in rats. Psychopharmakotherapy 9:19-24
104. Monteiro-Musten L, Firestone P, Pisterman S, Bennett S, Mercer J (1997) Effects of methylphenidate on preschool children with ADHD: Cognitive and behavioral functions. J Am Acad Child Adolesc Psychiatry 36:1407-1415
105. MTA Cooperative Group (1999a) A 14-month randomised clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086
106. MTA Cooperative Group (1999b) Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1088-1096
107. Nadder TS, Rutter M, Silberg JL, Maes HH, Eaves LJ (2002) Genetic effects on the variation and covariation of attention deficit-hyperactivity disorder (ADHD) and oppositional-defiant disorder/conduct disorder (Odd/CD) symptomatologies across informant and occasion of measurement. Psychol Med 32:39-53
108. Nehra A, Mullick F, Ishak KG, Zimmerman HJ (1990) Pemoline-associated hepatic injury. Gastroenterology 99:1517-1519
109. Neligan GA, Kolvin I, Scott DMcL, Garside RF (1976) Born Too Soon or Born Too Small. Clinics in Developmental Medicine No. 61. London, S.I.M.P./Heinemann
110. Nichols P, Chen T-C (1981) Minimal Brain Dysfunction: A Prospective Study. Hillsdale, NJ, Erlbaum
111. Oades RD (1998) Frontal, temporal and lateralized brain function in children with attention-deficit hyperactivity disorder: a psychophysiological and neuropsychological viewpoint on development. Behav Brain Res 94:83-95
112. Pelham WE, Wheeler T, Chronis A (1998) Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol 27:190-205
113. Pelham W, Waschbusch DA (1999) Behavioral intervention in attention-deficit/hyperactivity disorder. In: Quay H, Hogan AE (eds) Handbook of disruptive disorders. New York, Kluwer Academic/Plenum, pp 255-278
114. Pennington BF, Ozonoff S (1996) Executive functions and developmental psychopathology. J Child Psychol Psychiatry 37:51-87
115. Pennington BF, Groisser D, Welsh MC (1993) Contrasting cognitive deficits in attention deficit hyperactivity disorder versus reading disability. Devel Psychol 29:511-523
116. Pliszka SR (1989) Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Acad Child Adolesc Psychiatry 28:882-887
117. Prendergast M, Taylor E, Rapoport JL, Bartko J, Donnelly M, Zametkin A, Ahearn MB, Dunn G, Wieselberg HM (1988) The diagnosis of childhood hyperactivity: A U.S.-UK cross-national study of DSM-III and ICD-9. J Child Psychol Psychiatry 29:289-300
118. Quist JF, Barr CL, Schachar R, Roberts W, Malone M, Tannock R, Basile VS, Beitchman J, Kennedy JL (2003) The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Molecular Psychiatry 8:98-102
119. Reeve E, Garfinkel B (1991) Neuroendocrine and growth regulation: the role of sympathicomimetic medication. In: Greenhill L, Osman BB (eds) Ritalin: Theory and Management. New York, Liebert, pp 289-300
120. Riggs PD, Leon SL, Mikulich SK, Pottle LC (1998) An open trial of bupropion for AD/HD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 37:1271-1278
121. Robbins TW (2002) AD/HD and addiction. Nature Medicine 8:24-25
122. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291
123. Ross DM, Ross SA (1982) Hyperactivity: Current Issues. Research and Theory. New York, Wiley
124. Rothenberger A, Banaschewski T (2004) Tic-Disorders. In: Gillberg C, Harrington R, Steinhausen HC (eds) A Clinician's Handbook of Child and Adolescent Psychiatry. Cambridge, Cambridge University Press (in press)
125. Rothenberger A, Banaschewski T, Heinrich H, Moll GH, Schmidt MH, van't Klooster B (2000) Comorbidity in ADHD-children: effects of coexisting conduct disorder or tic disorder on event-related brain potentials in an auditory selective-attention task. Eur Arch Psychiatry Clin Neurosci 250:101-110
126. Rubia K, Overmeyer S, Taylor E, Brammer M, Williams SC, Simmons A, Bullmore ET (1999) Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am J Psychiatry 156:891-896
127. nd edn. Cambridge, Cambridge University Press, pp 417-434
128. Sagvolden T (2000) Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24:31-39
129. Sagvolden T, Sergeant JA (1998) Attention deficit/hyperactivity disorder - from brain dysfunctions to behaviour. Behav Brain Res 94:1-10
130. nd edn. Cambridge, Cambridge University Press, pp 367-416
131. Santosh PJ, Taylor E (2000) Stimulant drugs. Eur Child Adolesc Psychiatry 9 (Suppl 1):I27-I43
132. Schachar RJ, Rutter M, Smith A (1981) The characteristics of situationally and pervasively hyperactive children: implications for syndrome definition. J Child Psychol Psychiatry 22:375-392
133. Schachar R, Tannock R, Cunningham C (1996) Treatment. In: Sandberg S (ed) Hyperactivity Disorders of Childhood. Cambridge, Cambridge University Press, pp 433-476
134. th edn. Blackwell Publishing, pp 399-418
135. Scheres A, Oosterlaan J, Sergeant JA (2001) Response execution and inhibition in children with AD/HD and other disruptive disorders: the role of behavioural activation. J Child Psychol Psychiatry 42:347-357
136. Schleifer M, Weiss G, Cohen N, Elman M, Cvejic H, Kruger E (1975). Hyperactivity in pre-schoolers and the effect of methylphenidate. Am J Orthopsychiatry 45:38-50
137. Schmidt JK, Plück J, v. Gontard A (2002) Verzicht auf eine EEG-Diagnostik vor Beginn und unter einer Therapie mit Methylpenidat: gefährlich oder gerechtfertigt? Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 30:295-302
138. Schneider JS, Roeltgen DP (1993) Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys. Brain Research 615:351-354
139. Schubert I, Lehmkuhl G, Spengler A, Doepfner M, von Ferber L (2001) Methylphenidat bei hyperkinetischen Störungen. Deutsches Ärzteblatt 98:A541-A544
140. Schulte-Koerne G, Deimel W, Gutenbrunner C, Hennighausen K, Blank R, Rieger C, Remschmidt H (1996) Effect of an oligo-antigen diet on the behaviour of hyperkinetic children. Zeitschrift fuer Kinder- und Jugendpsychiatrie 24:176-183
141. Scottish Intercollegiate Guidelines Network (2001) Attention Deficit and Hyperactivity Disorders in Children and Young People. A National Clinical Guideline. Edinburgh, SIGN
142. Sergeant JA, Geurts H, Oosterlaan J (2002) How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder? Behav Brain Res 130:3-28
143. Sergeant J, Steinhausen H-C (1992) European perspectives on hyperkinetic disorder. Eur J Child Psychiatry 1:34-41
144. Shaffer D, Gould M S, Brasic J et al. (1983). A children's global assessment scale (CGAS). Arch Gen Psychiatry 40:1228-1231
145. Silberg J, Rutter M, Meyer J, Maes H, Hewitt J, Simonoff E, Pickles A, Loeber R, Eaves L (1996) Genetic and environmental influences of the covariation between hyperactivity and conduct disturbance in juvenile twins. J Child Psychol Psychiatry 37:803-816
146. Singer HS, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla MB (1995) The treatment of Attention Deficit-Hyperactivity Disorder in Tourette's syndrome: A double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 95:74-81
147. Smalley SL, Kustanovich V, Minassian SL, Stone JL, Ogdie MN, McGough JJ, McCracken JT, MacPhie IL, Francks C, Fisher SE, Cantor RM, Monaco AP, Nelson SF (2002) Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am J Human Gen 71:959-963
148. Smith KM, Daly M, Fischer M, Yiannoutsos CT, Bauer L, Barkley R, Navia BA (2003) Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study. Am J Med Gen 15;119B(1):77-85
149. Smith A, Taylor E, Rogers JW, Newman S, Rubia K (2002) Evidence for a pure time perception deficit in children with ADHD. J Child Psychol Psychiatry 43:529-542
150. Solanto MV, Abikoff H, Sonuga-Barke E, Schachar R, Logan GD, Wigal T, Hechtman L, Hinshaw S, Turkel E (2001) The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J Abnorm Child Psychol 29:215-228
151. Sonuga-Barke E (2003) The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci & Biobehav Rev 27:593-604
152. Sonuga-Barke EJ (2002) Psychological heterogeneity in AD/HD - a dual pathway model of behaviour and cognition. Behav Brain Res 130:29-36
153. Sonuga-Barke EJS, Daley D, Thompson M, Swanson J (2003) The management of preschool AD/HD; Addressing uncertainties about syndrome validity, diagnostic utility and treatment safety. Expert Reviews in Neurotherapeutics 3:89-100
154. Sonuga-Barke EJS, Dalen L, Remington RE (2003) Do delay aversion and inhibitory deficits make distinct contributions to pre-school AD/HD. J Am Acad Child Adolesc Psychiatry 42:1335-1342
155. Sonuga-Barke EJS, Daley D, Thompson M, Laver-Bradbury C, Weekes A (2001) Parent-based therapies for preschool attention-deficit/hyperactivity disorder: A randomized, controlled trial with a community sample. J Am Acad Child Adolesc Psychiatry 40:402-408
156. Sonuga-Barke EJS, Thompson M, Stevenson J, Viney D (1997) Patterns of behaviour problems among preschool children. Psychol Med 27:909-918
157. Sowell ER, Thompson PM, Welcome SE, Henkenius AL, Toga AW, Peterson BS (2003) Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 362(9397):1699-1707
158. Spencer T, Biederman J, Harding M, O'Donnell D, Faraone SV, Wilens TE (1996) Growth deficits in ADHD children revisited: Evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 35:1460-1469
159. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K (1995) A
160. Sprafkin J, Gadow KD, Nolan EE (2001) The utility of a DSM-IV-referenced screening instrument for attention deficit/hyperactivity disorder. J Emotion Behav Disord 9:182-191
161. Steinhausen H-C (1987) Global Assessment of Child Psychopathology. J Am Acad Child Adolesc Psychiatry 26:203-206
162. Swanson JM, Kraemer HC, Hinshaw S P, Arnold LE, Conners CK, Abikoff HB, Clevenger W, Davies M, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Owens EB, Pelham WE, Schiller E, Severe JB, Simpson S, Vitiello B, Wells K, Wigal T, Wu M (2001) Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 40:168-179
163. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PJ, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. The Lancet 351:9100:429-433
164. Taylor E, Chadwick O, Heptinstall E, Danckaerts M (1996) Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolesc Psychiatry 35:1213-1226
165. Taylor E, Sandberg ST (1984) Hyperactive behavior in English school-children: A questionnaire survey. J Abnorm Child Psychol 12:143-156
166. Taylor E, Sandberg S, Thorley G, Giles S (1991) The Epidemiology of Childhood Hyperactivity. Maudsley Monographs 33. Oxford, Oxford University Press
167. Taylor E, Schachar R, Thorle, G, Wieselberg M (1986) Conduct disorder and hyperactivity. Br J Psychiatry 149:760-767
168. Taylor E, Schachar R, Thorley G, Wieselberg HM, Event B, Rutter M (1987) Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychol Med 17:121-143
169. Taylor E, Sergeant J, Döpfner M, Gunning B, Overmeyer S, Mobius HJ, Eisert H-G (1998) Clinical guidelines for hyperkinetic disorder. Eur Child Adolesc Psychiatry 7:184-200
170. Taylor E (1994) Syndromes of attention deficit and overactivity. In: Rutter M, Taylor E, Hersov L (eds) Child and Adolescent Psychiatry: Modern Approaches. Oxford, Blackwell Scientific Publications, pp 285-307
171. Thapar A, Fowler T, Rice F, Scourfield J, van den Bree M, Thomas H, Harold G, Hay D (2003) Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry 160:1985-1989
172. Thapar A, Hervas A, McGuffin P (1995) Childhood hyperactivity scores are highly heritable and show sibling competition effects: twin study evidence. Behavior Gen 25:537-544
173. Thapar A, Holmes J, Poulton K, Harrington R (1999) Genetic basis of attention deficit and hyperactivity. Br J Psychiatry 174:105-111
174. Toplak ME, Rucklidge JJ, Hetherington R, John SC, Tannock R (2003) Time perception deficits in attention-deficit/hyperactivity disorder and comorbid reading difficulties in child and adolescent samples. J Child Psychol Psychiatry 44:888-903
175. Todd RD, Rasmussen ER, Neuman RJ, Reich W, Hudziak JJ, Bucholz KK, Madden PA, Heath A (2001) Familiality and heritability of subtypes of attention deficit hyperactivity disorder in a population sample of adolescent female twins. Am J Psychiatry 158:1891-1898
176. van Leeuwen TH, Steinhausen HC, Overtoom CC, Pascual-Marqui RD, van't Klooster B, Rothenberger A, Sergeant JA, Brandeis D (1998) The continuous performance test revisited with neuroelectric mapping: impaired orienting in children with attention deficits. Behav Brain Res 94:97-110
177. Volkow ND, Swanson JM (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of AD/HD. Am J Psychiatry 160:1909-1918
178. Volkow ND, Wang GJ, Fowler JS, Fischman M, Foltin R, Abumrad NN, Gatley SJ, Logan J, Wong C, Gifford A, Ding YS, Hitzemann R, Pappas N (1999) Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sciences 65:L7-L12
179. Wender PH, Wood DR, Reimherr FW (1985) Pharmacological treatment of attention deficit disorder, residual type. Psychopharmacol Bull 21:222-231
180. Wilens TE, Biederman J, Baldessarini RJ, Geller B, Schleifer D, Spencer TJ, Birmaher B, Goldblatt A (1996) Cardiovascular effets of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry 35:1491-1501
181. Wilens TE, Biederman J, Brown S, Tanguay S, Monuteaux MC, Blake C, Spencer TJ (2002) Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youths with ADHD. J Am Acad Child Adolesc Psychiatry 41:262-268
182. Wilens TE, Biederman J (1992) The stimulants. In: Shafer D (ed) Psychiatric Clinics of North America. Philadelphia, Pa., WB, Saunders, pp 191-222
183. Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T (1997) Attention deficit hyperactivity disorder (AD/HD) is associated with early onset substance use disorders. J Nerv Mental Dis 185:475-482
184. Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111:179-185
185. Willcutt EG, Pennington BF, Smith SD, Cardon LR, Gayan J, Knopik VS, Olson RK, DeFries JC (2002) Quantitative trait locus for reading disability on chromosome 6p is pleiotropic for attention-deficit/hyperactivity disorder. Am J Med Gen 114:260-268
186. Willcutt EG, Pennington BF, DeFries JC (2000) Twin study of the etiology of comorbidity between reading disability and attention-deficit/hyperactivity disorder. Am J Med Gen 96:293-301
187. World Health Organization (1996) Multiaxial classification of child and adolescent psychiatric disorders. The ICD-10 classification of mental and behavioral disorders in children and adolescents. Cambridge, Cambridge University Press
188. Yordanova J, Banaschewski T, Kolev V, Woerner W, Rothenberger A (2001) Abnormal early stages of task stimulus processing in children with attention-deficit hyperactivity disorder - evidence from event-related gamma oscillations. Clin Neurophysiol 112:1096-1108
189. Young E, Patel S, Stoneham M, Rona R, Wilkinson JD (1987) The prevalence of reaction to food additives in a survey population. Journal of the Royal College of Physicians of London 21:241-247
190. Zametkin AJ, Liebenauer LL, Fitzgerald GA, King AC, Minkunas DV, Herscovitch P, Yamada EM, Cohen RM (1993) Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 50:333-340